The role of pelvic exenteration and reconstruction for treatment of advanced or recurrent gynecologic malignancies: Analysis of risk factors predicting recurrence and survival

Journal of Surgical Oncology

Volumn 96, Issue 7, 2007, Pages 560-568

  Park, Jeong Yeol ^a   Hyuck, Jae Choi ^a   Jeong, Seung Yong ^a   Chung, Jinsoo ^a   Jung, Kun Park ^a   Park, Sang Yoon ^a  

^a National Cancer Center   (South Korea)

Author keywords

Gynecologic malignancy; Pelvic exenteration; Reconstruction

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; ENDOMETRIUM CANCER; FEMALE; GYNECOLOGIC CANCER; GYNECOLOGIC SURGERY; HUMAN; LYMPH NODE METASTASIS; MORBIDITY; MULTIVARIATE ANALYSIS; OVARY CANCER; OVERALL SURVIVAL; PELVIS EXENTERATION; PERITONEAL DISEASE; PLASTIC SURGERY; PREDICTOR VARIABLE; PRIORITY JOURNAL; RISK ASSESSMENT; SURVIVAL TIME; TUMOR VOLUME; UTERINE CERVIX CANCER; UTERUS SARCOMA; VAGINA CANCER; VULVA CANCER;

ADULT; AGED; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PELVIC EXENTERATION; PROSPECTIVE STUDIES; RECONSTRUCTIVE SURGICAL PROCEDURES; RISK FACTORS;

EID: 36549002187     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.20847     Document Type: Article

References (32)

1. Brunschwig A: Complete excision of pelvic viscera for advanced carcinoma. A one-stage abdominoperineal operation with end colostomy and bilateral ureteral implantation into colon above the colostomy. Cancer 1948;1:177-183.
2. Lopez MJ, Petros JG, Augustinus P: Development and evolution of pelvic exenteration: Historical notes. Semin Surg Oncol 1999;17:147-151.
3. Barber HR: Relative prognostic significance of preoperative and operative findings in pelvic exenteration. Surg Clin North Am 1969;49:431-447.
4. Monaghan J: Central recurrent cervical cancer: The role of exenterative surgery. In: Smith J, Del Priore G, Curtin J, Monaghan J, editors. An atlas of gynecologic oncology. Investigation and surgery. New York: Taylor & Francis 2005: pp 141-151.
5. Hockel M: Laterally extended endopelvic resection: Surgical treatment of infrailiac pelvic wall recurrences of gynecologic malignancies. Am J Obstet Gynecol 1999;180:306-312.
6. Hockel M, Sclenger K, Hamm H, et al.: Five-year experience with combined operative and radiotherapeutic treatment of recurrent gynecologic tumors infiltrating the pelvic wall. Cancer 1996;77:1918-1933.
7. Kaplan EL, Meier P: Nonparametric estimator from incomplete observations. J Amer Statist Ass 1958;53:457-481.
8. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966;50:163-170.
9. Cox DR: Retression models and life tables. Roy Statis Soc B 1972;34:187-220.
10. Kiselow M, Butcher HR Jr, Bricker EM: Results of the radical surgical treatment of advanced pelvic cancer: A fifteen-year study. Ann Surg 1967;166:428-436.
11. Hafner GH, Herrera L, Petrelli NJ: Morbidity and mortality after pelvic exenteration for colorectal adenocarcinoma. Ann Surg 1992;215:63-67.
12. Soper JT, Berchuck A, Creasman WT, et al.: Pelvic exenteration: Factors associated with major surgical morbidity. Gynecol Oncol 1989;35:93-98.
13. Anthopoulos AP, Manetta A, Larson JE, et al.: Pelvic exenteration: A morbidity and mortality analysis of a seven-year experience. Gynecol Oncol 1989;35:219-223.
14. Eisenkop SM, Spirtos NM: Procedures required to accomplish complete cytoreduction of ovarian cancer: Is there a correlation with "biological aggressiveness" and survival? Gynecol Oncol 2001;82:435-441.
15. Lopez MJ, Standiford SB, Skibba JL: Total pelvic exenteration. A 50-year experience at the Ellis Fischel Cancer Center. Arch Surg 1994; 390-395 discussion 395-396.
16. Ravi R: Second primary bladder cancer following pelvic irradiation for other malignancies. J Surg Oncol 1993;54:60-63.
17. Morley GW, Hopkins MP, Lindenauer SM, et al.: Pelvic exenteration, University of Michigan: 100 patients at 5 years. Obstet Gynecol 1989;74:934-943.
18. Rutledge FN, Smith JP, Wharton JT, et al.: Pelvic exenteration: Analysis of 296 patients. Am J Obstet Gynecol 1977;129:881-892.
19. Eisenkop SM, Nalick RH, Teng NN: Modified posterior exenteration for ovarian cancer. Obstet Gynecol 1991;78:879-885.
20. Sharma S, Odunsi K, Driscoll D, et al.: Pelvic exenterations for gynecological malignancies: Twenty-year experience at Roswell Park Cancer Institute. Int J Gynecol Cancer 2005;15: 475-482.
21. Kecmanovic DM, Pavlov MJ, Kovacevic PA, et al.: Management of advanced pelvic cancer by exenteration. Eur J Surg Oncol 2003;29:743-746.
22. Nguyen DQ, McGregor AD, Freites O, et al.: Exenterative pelvic surgery - eleven year experience of the Swansea Pelvic Oncology Group. Eur J Surg Oncol 2005;31:1180-1184.
23. Reid GC, Morley GW, Schmidt RW, et al.: The role of pelvic exenteration for sarcomatous malignancies. Obstet Gynecol 1989;74:80-84.
24. Pawlik TM, Skibber JM, Rodriguez-Bigas MA: Pelvic exenteration for advanced pelvic malignancies. Ann Surg Oncol 2006;13:612-623.
25. Shingleton HM, Soong SJ, Gelder MS, et al.: Clinical and histopathologic factors predicting recurrence and survival after pelvic exenteration for cancer of the cervix. Obstet Gynecol 1989;73:1027-1034.
26. Morrow C, Curtin J, Lopez de la Osa E: Surgery for cervical neoplsia. In: Morrow C, Curtin J, Lopez de la Osa E, editors. Gynecologic cancer surgery. New York: Churchill Liningstone 1996: pp 451-586.
27. Kakuda JT, Lamont JP, Chu DZ, et al.: The role of pelvic exenteration in the management of recurrent rectal cancer. Am J Surg 2003;186:660-664.
28. Goldberg JM, Piver MS, Hempling RE, et al.: Improvements in pelvic exenteration: Factors responsible for reducing morbidity and mortality. Ann Surg Oncol 1998;5:399-406.
29. Orr JW Jr, Shingleton HM, Hatch KD, et al.: Gastrointestinal complications associated with pelvic exenteration. Am J Obstet Gynecol 1983;145:325-332.
30. Roberts WS, Cavanagh D, Bryson SC, et al.: Major morbidity after pelvic exenteration: A seven-year experience. Obstet Gynecol 1987;69:617-621.
31. Coleman RL, Keeney ED, Freedman RS, et al.: Radical hysterectomy for recurrent carcinoma of the uterine cervix after radiotherapy. Gynecol Oncol 1994;55:29-35.
32. Maneo A, Landoni F, Cormio G, et al.: Radical hysterectomy for recurrent or persistent cervical cancer following radiation therapy. Int J Gynecol Cancer 1999;9:295-301.